- Home
- STEM vs KYTX Comparison
STEM vs KYTX Comparison
Compare STEM & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEM
- KYTX
- Stock Information
- Founded
- STEM 2009
- KYTX 2018
- Country
- STEM United States
- KYTX United States
- Employees
- STEM N/A
- KYTX N/A
- Industry
- STEM Computer Software: Prepackaged Software
- KYTX
- Sector
- STEM Technology
- KYTX
- Exchange
- STEM Nasdaq
- KYTX NYSE
- Market Cap
- STEM 135.7M
- KYTX 130.8M
- IPO Year
- STEM N/A
- KYTX 2024
- Fundamental
- Price
- STEM $0.56
- KYTX $2.78
- Analyst Decision
- STEM Hold
- KYTX Buy
- Analyst Count
- STEM 8
- KYTX 5
- Target Price
- STEM $1.38
- KYTX $23.20
- AVG Volume (30 Days)
- STEM 7.6M
- KYTX 468.8K
- Earning Date
- STEM 03-04-2025
- KYTX 03-04-2025
- Dividend Yield
- STEM N/A
- KYTX N/A
- EPS Growth
- STEM N/A
- KYTX N/A
- EPS
- STEM N/A
- KYTX N/A
- Revenue
- STEM $256,183,000.00
- KYTX N/A
- Revenue This Year
- STEM N/A
- KYTX N/A
- Revenue Next Year
- STEM $103.37
- KYTX N/A
- P/E Ratio
- STEM N/A
- KYTX N/A
- Revenue Growth
- STEM N/A
- KYTX N/A
- 52 Week Low
- STEM $0.30
- KYTX $2.65
- 52 Week High
- STEM $3.00
- KYTX $30.60
- Technical
- Relative Strength Index (RSI)
- STEM 47.10
- KYTX 36.42
- Support Level
- STEM $0.47
- KYTX $2.65
- Resistance Level
- STEM $0.72
- KYTX $3.11
- Average True Range (ATR)
- STEM 0.07
- KYTX 0.22
- MACD
- STEM 0.00
- KYTX 0.01
- Stochastic Oscillator
- STEM 37.80
- KYTX 17.88
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on innovative technology services that transform the way energy is distributed and consumed.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.